PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Period	PE Ratio
2021-12-31	-6.92
2022-12-31	-12.82
2023-12-31	-11.21
2024-12-31	-14.35

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRCT	$25.12	+0.00%	0.80M
3
4
5

PROCEPT BioRobotics Corporation (PRCT) PE Ratio

PE Ratio Data

Get PROCEPT BioRobotics Corporation Data in Excel

More PRCT Financial Data